XML 149 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Equity
12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Equity
Note 14 – Equity
Share Activity
During the fourth quarter of 2014, the Company’s Board of Directors authorized a $100 million share repurchase program (the “2014 Share Repurchase Program”). No shares of the Company’s common stock had been repurchased under this program as of December 31, 2014. Under the 2014 Share Repurchase Program, the Company may repurchase shares from time to time in open market transactions or in privately-negotiated transactions in accordance with applicable securities laws. The timing and the amount of any repurchases will be determined based on market conditions, legal requirements, cash flow and liquidity needs and other factors. The share repurchase program may be modified or suspended at any time, at the Company’s discretion. Share repurchases, which are recorded at cost and are held in the Company’s treasury, will be funded with available cash or with availability under the Credit Facility. Subsequent to December 31, 2014, the Company repurchased shares under the 2014 Share Repurchase Program. As of April 2015, the Company had repurchased approximately 5.2 million shares of its common stock for an aggregate purchase price of approximately $100 million, which completed the 2014 Share Repurchase Program. Additionally, during the year ended December 31, 2012, the Company repurchased 4.9 million shares of its common stock under a $150 million share repurchase program that was authorized by the Company’s Board of Directors in 2011 (the “2011 Share Repurchase Program”). The aggregate purchase price of the repurchased shares for the year ended December 31, 2012 totaled $75 million, which completed the program.
The Company may use either authorized and unissued shares or treasury shares to meet share issuance requirements, including those resulting from the exercise of stock options, vesting of restricted shares and other share issuance requirements. During the year ended December 31, 2014, the Company reissued a total of 6.6 million shares of its treasury stock with a cost basis of $104.4 million in settlement of its senior convertible notes, which matured and were converted in 2014. See Note 10 - Debt.
Comprehensive Income
Comprehensive income is a measure of net income and other changes in equity that result from transactions other than those with shareholders. Comprehensive income consists of net income, foreign currency translation adjustments, unrealized gains and losses from available-for-sale securities and net income (loss) attributable to non-controlling interests. See consolidated statements of comprehensive income for details.
Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss activity for the periods indicated was as follows (in thousands):
 
 
For the Years Ended December 31,
 
 
2014
 
2013
 
2012
 
 
Unrealized (Losses) Gains
 
 
Foreign Currency
 
Other
 
Total
 
Foreign Currency
 
Other
 
Total
 
Foreign Currency
 
Other
 
Total
Balance as of January 1
 
$
(7,998
)
 
$
(5,288
)
 
$
(13,286
)
 
$
(105
)
 
$
(5,396
)
 
$
(5,501
)
 
$
(2,029
)
 
$
(5,917
)
 
$
(7,946
)
Activity before reclassifications, net of tax
 
(20,718
)
 

 
(20,718
)
 
(7,893
)
 
337

 
(7,556
)
 
1,924

 
521

 
2,445

Reclassifications, net of tax
 

 

 

 

 
(229
)
 
(229
)
 

 

 

Activity, net of tax
 
$
(20,718
)
 
$

 
$
(20,718
)
 
$
(7,893
)
 
$
108

 
$
(7,785
)
 
$
1,924

 
$
521

 
$
2,445

Balance as of December 31
 
$
(28,716
)
 
$
(5,288
)
 
$
(34,004
)
 
$
(7,998
)
 
$
(5,288
)
 
$
(13,286
)
 
$
(105
)
 
$
(5,396
)
 
$
(5,501
)

Unrealized foreign currency gains and losses relate primarily to fluctuations in foreign currency exchange rates of the Company’s foreign subsidiaries with a functional currency other than the U.S. dollar. Foreign currency activity for the years ended December 31, 2014, 2013 and 2012 related primarily to the Company’s Canadian operations. The Company’s Canadian presence has grown in recent years due to acquisitions. See Note 4 - Acquisitions.